Get the Stockscreener App
6.00
1.64%
-0.10
Generation Bio Co stock is traded at $6.00, with a volume of 42,561.
It is down -1.64% in the last 24 hours and up +0.00% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$6.10
Open:
$6.11
24h Volume:
42,561
Relative Volume:
0.16
Market Cap:
$40.41M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.8859
EPS:
-6.7728
Net Cash Flow:
$-81.69M
1W Performance:
-4.91%
1M Performance:
+0.00%
6M Performance:
+40.48%
1Y Performance:
-71.96%
1-Day Range:
$5.90
$6.11
1-Week Range:
$5.90
$6.48
52-Week Range:
$3.004
$25.70
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
6.00 | 41.09M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Is Generation Bio Co. stock reversal real or fakePortfolio Value Summary & Risk Managed Investment Signals - newser.com
Sentiment analysis tools applied to Generation Bio Co.Weekly Market Summary & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Generation Bio Co.Earnings Summary Report & Free Community Consensus Stock Picks - newser.com
Is Generation Bio Co. stock bottoming outJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Will Generation Bio Co. stock go up soonFed Meeting & Real-Time Volume Analysis Alerts - newser.com
Using data models to predict Generation Bio Co. stock movementAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Volume spikes in Generation Bio Co. stock – what they meanMarket Activity Report & Expert-Curated Trade Recommendations - newser.com
What the charts say about Generation Bio Co. todayAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Why analysts upgrade Generation Bio Co. stockEarnings Miss & Community Driven Trade Alerts - newser.com
Chart overlay techniques for tracking Generation Bio Co.Analyst Downgrade & Reliable Price Action Trade Plans - newser.com
Short interest data insights for Generation Bio Co.July 2025 Drop Watch & Advanced Technical Signal Analysis - newser.com
Will Generation Bio Co. stock sustain high P E ratiosJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
Is Generation Bio Co. stock oversold or undervaluedMarket Trend Summary & Weekly Breakout Watchlists - Fundação Cultural do Pará
Is this a good reentry point in Generation Bio Co.Weekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):